Results 51 to 60 of about 10,710,575 (236)

Amyloid tumor of the breast

open access: yesSurgical Case Reports, 2019
Background Amyloid tumor of the breast is a rare disease, which was first reported in 1973. To date, only six cases have been reported in Japan. Case presentation A 45-year-old woman who had a medical history of Sjogren’s syndrome presented with a lump ...
Makiko Mori   +12 more
doaj   +1 more source

Supervised risk predictor of breast cancer based on intrinsic subtypes.

open access: yesJournal of Clinical Oncology, 2009
UNLABELLED PURPOSE To improve on current standards for breast cancer prognosis and prediction of chemotherapy benefit by developing a risk model that incorporates the gene expression-based "intrinsic" subtypes luminal A, luminal B, HER2-enriched, and ...
J. Parker   +19 more
semanticscholar   +1 more source

Breast Cancer Risk Genes — Association Analysis in More than 113,000 Women

open access: yesNew England Journal of Medicine, 2021
Background Genetic testing for breast cancer susceptibility is widely used, but for many genes, evidence of an association with breast cancer is weak, underlying risk estimates are imprecise, and reliable subtype-specific risk estimates are lacking ...
L. Dorling   +196 more
semanticscholar   +1 more source

RETRACTED ARTICLE: GGNBP2 suppresses triple-negative breast cancer aggressiveness through inhibition of IL-6/STAT3 signaling activation

open access: yes, 2018
Background Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer, lacking effective targeted therapies, and whose underlying mechanisms are still unclear.
Liu, Jingjing   +7 more
core   +1 more source

Neoadjuvant camrelizumab plus nab-paclitaxel and epirubicin in early triple-negative breast cancer: a single-arm phase II trial

open access: yesNature Communications, 2023
Immunotherapy combined with chemotherapy has been demonstrated to be effective in early triple-negative breast cancer (TNBC). In this single-arm, phase II study with Simon’s two-stage design, we investigated the efficacy and safety of neoadjuvant ...
Chengzheng Wang   +11 more
doaj   +1 more source

Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

open access: yesCa
This article presents global cancer statistics by world region for the year 2022 based on updated estimates from the International Agency for Research on Cancer (IARC).
F. Bray   +6 more
semanticscholar   +1 more source

A Population-Based Study of Genes Previously Implicated in Breast Cancer

open access: yesNew England Journal of Medicine, 2021
BACKGROUND Population-based estimates of the risk of breast cancer associated with germline pathogenic variants in cancer-predisposition genes are critically needed for risk assessment and management in women with inherited pathogenic variants.
Chun-Ling Hu   +59 more
semanticscholar   +1 more source

Patterns of Practice in Radiotherapy for Breast Cancer in Korea. [PDF]

open access: yes, 2018
Adjuvant radiotherapy (RT) is a well-established treatment for breast cancer. However, there is a large degree of variation and controversy in practice patterns.
김용배, 서창옥
core   +1 more source

Guidelines for the Diagnosis and Treatment of Advanced Breast Cancer in China (2024 Edition)

open access: yesCancer Innovation
Breast cancer is the most common malignant tumor among women globally. In 2022, there were approximately 357,161 new cases and 74,986 deaths from breast cancer among Chinese females.
Breast Cancer Expert Committee of the National Quality Control Center for Cancer   +2 more
doaj   +1 more source

Influence of stromal–epithelial interactions on breast cancer in vitro and in vivo

open access: yes, 2019
Stromal cell-secreted chemokines including CCL2 have been implicated in the primary tumor microenvironment, as mediators of tumor cell migration, proliferation, and angiogenesis.
Dwyer, Róisín M.   +6 more
core   +1 more source

Home - About - Disclaimer - Privacy